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Abstract
Background: While upper-extremity movement in individuals with neurological disorders such as
stroke and spinal cord injury (SCI) has been studied for many years, the effects of spasticity on arm
movement have been poorly quantified. The present study is designed to characterize the nature
of impaired arm movements associated with spasticity in these two clinical populations. By
comparing impaired voluntary movements between these two groups, we will gain a greater
understanding of the effects of the type of spasticity on these movements and, potentially a better
understanding of the underlying impairment mechanisms.
Methods: We characterized the kinematics and kinetics of rapid arm movement in SCI and
neurologically intact subjects and in both the paretic and non-paretic limbs in stroke subjects. The
kinematics of rapid elbow extension over the entire range of motion were quantified by measuring
movement trajectory and its derivatives; i.e. movement velocity and acceleration. The kinetics were
quantified by measuring maximum isometric voluntary contractions of elbow flexors and
extensors. The movement smoothness was estimated using two different computational
techniques.
Results: Most kinematic and kinetic and movement smoothness parameters changed significantly
in paretic as compared to normal arms in stroke subjects (p < 0.003). Surprisingly, there were no
significant differences in these parameters between SCI and stroke subjects, except for the
movement smoothness (p ≤ 0.02). Extension was significantly less smooth in the paretic compared
to the non-paretic arm in the stroke group (p < 0.003), whereas it was within the normal range in
the SCI group. There was also no significant difference in these parameters between the non-
paretic arm in stroke subjects and the normal arm in healthy subjects.
Conclusion: The findings suggest that although the cause and location of injury are different in
spastic stroke and SCI subjects, the impairments in arm voluntary movement were similar in the
two spastic groups. Our results also suggest that the non-paretic arm in stroke subjects was not
distinguishable from the normal, and might therefore be used as an appropriate control for studying
movement of the paretic arm.
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Introduction
The movement impairments following neurological ill-
ness such as stroke and spinal cord injury are caused by
disturbances in descending commands, although the pre-
cise mechanisms by which disrupted commands affect
voluntary function are uncertain. However, several mech-
anisms including abnormal muscle recruitment, weakness
and spasticity have been suggested as contributing factors
[1,2]. Spasticity is a motor disorder associated with lesions
at different levels of the nervous system. It can directly or
indirectly change mechanical properties of the neuromus-
cular system, particularly in chronic patients, and has
been linked to impaired voluntary movement through
different mechanisms [3-7].
It is possible that the nature of the movement impair-
ments are different in spastic subjects with different etiol-
ogies of spasticity, such as between stroke and SCI. For
example, a combination of upper motor neuron and
lower motor neuron impairment may occur in many cer-
vical SCI patients where the anterior horn cells at the site
of injury are injured and may dampen the magnitude of
the normal spastic response at this level, thereby dimin-
ishing spastic resistance to the movement. Therefore,
comparison of impaired voluntary movement between
stroke and SCI groups is warranted to understand possible
effects of the etiology of spasticity on the nature of these
impairments and their underlying mechanisms.
Previous studies have focused on reaching and grasping
movements for individuals with stroke or SCI [8-10]. The
effects of spasticity on elbow movement, however, have
not been fully characterized. In stroke, although some
kinematic parameters of the spastic arm have been meas-
ured [11-13], some unresolved issues remain. First, elbow
movement has been described over only a narrow portion
of its range of motion (ROM). To fully characterize
impairments it is critically important to examine elbow
joint movement over the entire ROM since mechanical
abnormalities of spastic joints are maximized at the
extremes of the ROM, as shown previously [5,14]. Sec-
ondly, although lack of or reduced smoothness is a major
problem in voluntary arm movement, previous studies
have focused on distal (i.e., hand) movement [15], with
little information available on the smoothness of move-
ment trajectories at the elbow.
Experimental studies on arm movement dysfunction in
patients with SCI have focused on functional limitations
caused by contracture or paralysis of the arm [16,17].
Compared to stroke, even less quantitative information
exists regarding the performance of the spastic elbow in
patients with SCI is available, perhaps due to difficulty
accessing appropriate subjects.
In the present study, we were interested in addressing
these deficits and testing whether impairments in volun-
tary arm movement differed in patients with different ori-
gins of spasticity (in this study, subjects with stroke and
SCI). By comparing the impaired voluntary movement
between these two groups, we sought to gain a greater
understanding of the effects of the type of spasticity (i.e.
spinal or cerebral) on these movements. To fully charac-
terize different kinematic, kinetic and movement smooth-
ness parameters, we quantified voluntary full flexion/
extension movements of the elbow at maximum speed.
Full range of motion and maximum speed are required to
elicit certain movement impairments, such as reduced
smoothness. We postulated the existence of several differ-
ent abnormalities in upper extremity kinematics in sub-
jects with stroke versus SCI, in paretic versus non-paretic
arms of hemiparetic stroke survivors, and in SCI versus
healthy subjects.
Methods
Subjects
Patients with paretic arms, ten due to stroke, and eight due
to incomplete SCI; and 10 healthy subjects were recruited
to participate in this study. The inclusion criteria for stroke
subjects were stable medical condition, absence of expres-
sive or receptive aphasia, absence of sensory or motor
neglect in the paretic arm, absence of muscle tone abnor-
malities in the non-paretic arm, absence of motor or sen-
sory deficits in the non-paretic arm, absence of severe
muscle wasting or sensory deficits in the paretic arm, spas-
ticity present in the paretic arm, and at least 12 months
post-stroke. The inclusion criteria for SCI subjects were
traumatic, non-progressive SCI with an American Spinal
Injury Association (ASIA) impairment scale classification
of C or D indicating motor incomplete lesions, neurolog-
ical level of C4–C5, spasticity present in the arm, and min-
imum 1 year post-injury.
Healthy subjects with a mean age of 45 ± 12.3 SD years
were age-matched to the stroke and SCI subjects (49.7 ±
10.2 SD years and 42 ± 8.3 SD, respectively), and with no
history of neuromuscular disease served as controls. All
the subjects gave informed consent to the experimental
procedures, which had been reviewed and approved by
the Institutional Review Board of Northwestern Univer-
sity.
Clinical assessment
Stroke survivors and SCI subjects were assessed clinically
prior to each experiment using the modified 6-point Ash-
worth scale (MAS) to assess muscle tone (see Table 1)
[18,19].
In SCI subjects with incomplete motor function loss, the
sides of the body are often affected differently, so, bothJournal of NeuroEngineering and Rehabilitation 2007, 4:45 http://www.jneuroengrehab.com/content/4/1/45
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sides were assessed in this study. The side with the highest
modified Ashworth scale and lowest isometric maximum
elbow extension torque, which were always on the same
side, was studied.
The MAS scores varied between 1 and 4 in both stroke and
SCI groups.
Apparatus
Figure 1 shows a schematic diagram of the apparatus. Sub-
jects were seated and strapped to an adjustable experi-
mental chair with the forearm attached to the beam of the
apparatus mounted on a torque cell by a custom fitted fib-
erglass cast. The seat was adjusted to provide a shoulder
abduction of 80 degrees. The axis of elbow rotation was
aligned with the axis of the torque sensor and potentiom-
eter.
Procedures
Subjects were asked to move their forearm from full elbow
flexion to extension at maximum speed, with shoulder
flexion angle was set at zero degrees. These movements
were recorded 5 times and ensemble-averaged. We found
that 5 trials provided a strong estimate of mean move-
ment performance, since the typical standard deviation of
the movement trajectory was less than 10%.
Table 1: Modified Ashworth Scale – (MAS) [18]
Grade Description
0 No increase in muscle tone
1 Slight increase in muscle tone, manifested by a catch and 
release or by minimal resistance at the end of the range of 
motion (ROM) when the affected part(s) is moved in flexion 
or extension.
1+ Slight increase in muscle tone, manifested by a catch, 
followed by minimal resistance throughout the remainder 
(less than half) of the ROM.
2 More marked increase in muscle tone through most of the 
ROM, but affected part(s) easily moved.
3 Considerable increase in muscle tone, passive movement 
difficult.
4 Affected part(s) rigid in flexion or extension.
The apparatus including the height adjustable chair, and force and position sensors Figure 1
The apparatus including the height adjustable chair, and force and position sensors.Journal of NeuroEngineering and Rehabilitation 2007, 4:45 http://www.jneuroengrehab.com/content/4/1/45
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The elbow position and the torque were measured with a
precision potentiometer and torque transducer. Displace-
ments in the flexion direction were taken as negative and
those in the extension direction as positive. An elbow
angle of 90 degrees was considered the Neutral Position
(NP) and defined as zero. Torque was assigned a polarity
consistent with the direction of the movement that it
would generate (i.e. extension torque was taken as posi-
tive).
Both the paretic and non-paretic arms were assessed in
individuals with stroke, more affected arm in individuals
with SCI (spastic SCI) and the dominant arm in the
healthy controls (normal).
Data analysis
Kinematics
Angular velocity and acceleration were calculated from
the first and second derivatives of the elbow angular posi-
tion data (Figure 2), respectively. The position, velocity,
and acceleration data were used to quantify kinematic
parameters: i.e., peak angular velocity (Vp), latency to
peak angular velocity (TVp), peak angular acceleration
(Ap), latency to peak acceleration (TAp), movement time
(MT), active range of motion (AROM), and movement
smoothness. The MT, AROM, onset and end of an elbow
extension were determined from the velocity profile. The
onset and end of each movement were defined as the first
sample with velocity larger and smaller, respectively, than
5% of Ap [20].
Kinetics
All study participants were asked to generate an isometric
maximum voluntary contraction (MVC) in the direction
of elbow extension at the NP for 5 seconds. The process
was performed 3 times and measurements were averaged.
Movement smoothess
Impaired voluntary movements of spastic arms are char-
acterized by the loss of smoothness in the movement tra-
jectory [13,21,22]. In healthy subjects movement
trajectories are smooth (Fig. 2-A1) with single-peaked,
bell-shaped velocity profiles (i.e. single acceleration phase
followed by a single deceleration phase) (Fig. 2-B1). In
contrast, movement trajectories from spastic subjects are
rippled (Fig. 2-A2), and with multiple peaks and irregular-
ities in both velocity (Fig. 2-B2) and acceleration (Fig. 2-
C2). Two major computational methods were used to
measure movement smoothness.
Number of movement unit (NMU)
The NMU of the movement trajectory was defined as the
total number of velocity peaks between the onset and off-
set of the movement [23] (Fig. 2-B2). A velocity peak was
identified in the acceleration profile as the point where
the trajectory crossed the zero line and the sign of acceler-
ation changed from positive (accelerating) to negative
(decelerating) as shown in Fig. 2-C2.
Normalized jerk score (NJS)
The NJS was computed from the jerk, which was defined
by Kitazawa, et al.[24]as the third derivative of the angular
position, used as the index of trajectory smoothness. It
successfully captures the jerkiness of reaching movements
in monkeys with limb ataxia [24]. The NJS was calculated
from Equation-1:
where
Pi: Elbow angular position at the ith sample
t1: Onset of movement
t2: Offset of movement
d3p/dt3: Third derivative of the angular position data
t: Movement time
Pt2 - Pt1: AROM
Statistical analysis
Non-parametric Wilcoxon rank tests were used for group
comparisons (e.g. paretic versus non-paretic limbs in
stroke, paretic limbs in stroke versus spastic limbs in SCI;
non-paretic limbs in stroke versus normal limbs; spastic
SCI limbs versus normal limbs). We used Wilcoxon
matched pairs signed rank sum test for the comparison of
the two sides of the stroke subjects, and Wilcoxon signed
rank sum test for the comparison between arm measure-
ments in other groups. All statistical analyses were per-
formed using SAS statistical software (SAS 9.1.3. SAS Inc.
Cary, NC). A Bonferroni correction was used to adjust the
alpha level for all our statistical comparisons. We made
four group comparisons, therefore, a significance level
was set at 0.013 (= 0.05/4).
Spearmen correlation coefficients were computed to test
the relationship between the kinematic, kinetic and
movement smoothness measures and Ashworth scores in
the paretic and spastic SCI arms.
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A typical movement trajectory of rapid elbow extension generated by a normal and a stroke subject Figure 2
A typical movement trajectory of rapid elbow extension generated by a normal and a stroke subject. Normal: A1 Position; B1 
Velocity; and C1 Acceleration. Stroke: A2 Position; B2 Velocity; and C2 Acceleration. Circles in B2, C2 represent zero-
crossings in the acceleration. MT: movement time, AROM: active range of motion, Vp: peak velocity, Ap: peak acceleration, 
TVp: the latency to peak velocity, TAp: the latency to peak acceleration.Journal of NeuroEngineering and Rehabilitation 2007, 4:45 http://www.jneuroengrehab.com/content/4/1/45
Page 6 of 15
(page number not for citation purposes)
Results
Paretic versus non-paretic arm in stroke subjects
We quantified the impairments during the rapid elbow
extension movement of the spastic upper limb. Figure 3A
shows the movement trajectory (top panel), velocity
(middle panel), and acceleration (bottom panel) for the
paretic and the non-paretic arm in a representative stroke
survivor. For the paretic arm, the AROM was 60 degrees
(60%) smaller, and MT was 3 seconds (approximately 4
times) longer than that of the non-paretic arm. The peak
velocity and peak acceleration were approximately 85%
and 90% smaller, respectively, in the paretic than in the
non-paretic arm.
Figure 3B shows the group means and standard deviations
of the kinematic, kinetic and smoothness parameters for
paretic and non-paretic arms. Impairments were evident
in most of these parameters. MT was significantly longer,
Vp and Ap smaller, AROM smaller, and MVC lower (each
at p < 0.001). There was no significant difference (p > 0.1)
between paretic and non-paretic arms in latencies to peak
velocity and acceleration (TVp, TAp).
Movement of the paretic arm was jerky, indicated by the
ripples on the movement trajectory, velocity, and acceler-
ation graphs (Figure 3A). The group results show that
NMU and NJS were significantly larger in the paretic than
the non-paretic arm (p < 0.01). The NMU and NJS were
more than 4 and 8 times larger, respectively, in the paretic
than in the non-paretic arm indicating jerky movement.
Non-paretic arm versus normal arm
It has been suggested that the non-paretic limb can be
influenced to some extent by stroke [25,26]. We probed
this claim in elbow extension movement by comparing
the kinematics, kinetics and smoothness parameters of
non-paretic elbow movement to those of healthy subjects
(Normal). Figure 4 shows typical movement trajectories
of non-paretic and normal arms. The non-paretic arm
showed a slightly slower movement and less smooth tra-
jectory than the normal arm. In the non-paretic arm,
AROM was ~8% smaller, MT was ~45% longer, and Vp
and Ap were ~30%, ~36% lower, respectively. The posi-
tion trajectory for the non-paretic arm and its related
velocity and acceleration had a small but typical extra rip-
ple, indicating a mild jerkiness. Although the non-paretic
arms seem to show mild impairments in the movement
trajectory, there were no significant differences in kine-
matic and kinetic parameters between the non-paretic and
normal groups (p > 0.11). These findings suggest that
although the non-paretic arm is not entirely "normal", it
may be considered as a suitable control to eliminate the
effects of inter-subject variability.
Spastic arm in SCI versus normal arm
Representative movement trajectories of spastic arms in
subjects with SCI and normal arms are shown in Figure
5A. In SCI subjects, AROM was ~42% smaller, MT was
approximately 7 times longer and Vp and Ap were over
70% smaller.
The group results indicate that all these kinematic param-
eters were significantly changed in the spastic SCI arm
(Figure 5B, p < 0.01). Furthermore, MVC in the spastic SCI
arm was significantly smaller than in the Normal arm (p
< 0.01). There were no significant differences in other
movement parameters (p > 0.1).
Mild jerkiness was also evident in the subject with SCI as
an extra ripple in the graphs of movement trajectory,
velocity and acceleration (Figure 5A). However, there was
no significant difference in the smoothness measures
between the group results of the spastic SCI and healthy
subjects (p > 0.21).
Paretic arm in stroke versus spastic arm in SCI
Figure 6 shows typical movement trajectories of the
paretic arm in stroke and the spastic arm in SCI. Move-
ment impairments, including long MT, small Vp and Ap
and jerky movements were evident in both paretic and
spastic SCI arms. However, there were no significant dif-
ferences in kinematics, kinetics, or movement smooth-
ness in the group results for these two patient populations
(p > 0.17).
Descriptive subgroup analysis
There was no significant difference in movement impair-
ments between the paretic arm and the spastic SCI arm.
However, movement trajectories of the paretic arm
seemed less smooth than the spastic SCI arm. In an
attempt to possibly detect the reduced smoothness, we
computed the AROM generated during the first move-
ment unit (AROM_1MU), and the percentage of AROM
covered by the first movement unit (%AROM_1MU) in
paretic and spastic SCI arms. These two measures indicate
a person's ability to precisely scale movement velocity and
muscle forces such that a task can be accomplished in a
single accelerating and decelerating cycle [23]. If the task
can be completed at the first attempt, further minor
adjustments of the arm are not needed; the overall move-
ment is continuous and smooth. Therefore, AROM_1MU
and %AROM_1MU may also provide an alternative to
characterize movement smoothness and help differentiate
impairments in voluntary control between paretic and
spastic SCI groups.
To eliminate the effect of the large inter-subject variability
observed in paretic and spastic SCI groups, patients were
assigned to either a "Good Performance" group (G) or aJournal of NeuroEngineering and Rehabilitation 2007, 4:45 http://www.jneuroengrehab.com/content/4/1/45
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A Movement trajectories of elbow angular position, velocity and acceleration of the paretic arm (dotted-line) and the non- paretic arm (solid-line) in a typical stroke subject Figure 3
A Movement trajectories of elbow angular position, velocity and acceleration of the paretic arm (dotted-line) and the non-
paretic arm (solid-line) in a typical stroke subject; B Kinematic, kinetic and smoothness parameters which are significantly dif-
ferent between the paretic and non-paretic arms: MT: movement time; Vp: Peak velocity; Ap: peak acceleration; AROM: active 
range of motion; MVC: isometric muscle strength of elbow extensors; NJS: normalized jerk score; NMU: number of movement 
unit. Group average ± Standard deviation.Journal of NeuroEngineering and Rehabilitation 2007, 4:45 http://www.jneuroengrehab.com/content/4/1/45
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"Fair-Poor Performance" (FP) group by comparing indi-
vidual values of MT, AROM, MVC, Vp, and AROM_1MU
to the group means. If the value of a particular parameter
was larger (for AROM, MVC, Vp, and AROM_1MU) or
smaller (for MT) than the group mean, that parameter was
coded 1, otherwise coded 0. Coding scores from these five
parameters were added for each subject to form a sum
score. A subject was assigned to the G group if his/her sum
score was greater than the group median score (the
median of the sum scores of the whole group) and to the
FP group if his/her sum score was equal to or smaller than
the group median score. Kinematic, kinetic and smooth-
ness parameters were compared between paretic and spas-
tic SCI arms in each performance group.
In the G group, there were no significant differences
between the paretic and spastic SCI arms. In the FP group,
AROM_1MU and %AROM_1MU were significantly larger
for spastic SCI arms than paretic arms (p ≤ 0.02), but there
were no significant differences in other parameters.
Correlation between movement and clinical measures
We found no significant correlations (r < 0.5) between the
Ashworth scores and our objective measures of voluntary
movement.
Movement trajectories of elbow angular position, velocity and acceleration of the non-paretic arm (dotted-line) in a typical  stroke subject and the normal arm in a typical healthy subject (normal; solid-line) Figure 4
Movement trajectories of elbow angular position, velocity and acceleration of the non-paretic arm (dotted-line) in a typical 
stroke subject and the normal arm in a typical healthy subject (normal; solid-line).Journal of NeuroEngineering and Rehabilitation 2007, 4:45 http://www.jneuroengrehab.com/content/4/1/45
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A Movement trajectories of elbow angular position, velocity, and acceleration of the spastic arm in a typical SCI subject (spastic  SCI; dotted-line) and the normal arm in a typical healthy subject (Normal; solid-line) Figure 5
A Movement trajectories of elbow angular position, velocity, and acceleration of the spastic arm in a typical SCI subject (spastic 
SCI; dotted-line) and the normal arm in a typical healthy subject (Normal; solid-line); B Kinematic, kinetic and smoothness var-
iables which are significantly different between the spastic SCI and Normal arms: MT: movement time; TVp: latency to peak 
velocity; Vp: Peak velocity; Ap: peak acceleration; AROM: active range of motion; MVC: isometric muscle strength of elbow 
extensors. Group average ± Standard deviation.Journal of NeuroEngineering and Rehabilitation 2007, 4:45 http://www.jneuroengrehab.com/content/4/1/45
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Discussion
This study clarifies several important issues regarding
impaired voluntary movement of the spastic elbow in
patients with neurological disorders. In particular we
characterized the nature of the impairments in voluntary
movement of two spastic populations.
A number of new insights into movement impairments
were provided by this study. First, most kinematic and
kinetic parameters were significantly changed in the
paretic arm in stroke and the spastic arm in SCI. In addi-
tion, the effective methods for measuring movement
smoothness were determined; differences in movement
smoothness between patients following stroke and SCI
were evident only when subjects with fair to poor perform-
ances (FP) were compared. Interestingly, clinical meas-
ures of spasticity (i.e., Ashworth scores) were not related
to these objective, voluntary movement parameters.
Finally, abnormal kinematics for the non-paretic limb of
patients post-stroke indicated a degree of abnormality.
However, these changes were not significant, suggesting
that the non-paretic limb might be an appropriate control
for the paretic arm as it eliminates the effects of inter-sub-
ject variability.
Movement trajectories of paretic in stroke (dotted-line) and of spastic in SCI (solid-line) arms Figure 6
Movement trajectories of paretic in stroke (dotted-line) and of spastic in SCI (solid-line) arms.Journal of NeuroEngineering and Rehabilitation 2007, 4:45 http://www.jneuroengrehab.com/content/4/1/45
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Taken together, our findings provide a better understand-
ing of the nature of movement impairments associated
with spasticity in patients following stroke and SCI. The
similarities and differences in the kinematics and kinetics
of the non-paretic and healthy arm provide necessary
information for the design and execution of movement
studies in stroke subjects.
Impaired voluntary movement in the paretic arm: 
kinematics and kinetics
We provide details of movement impairments throughout
the full angular range of motion of the elbow, recorded at
maximum movement speed, a movement and speed
range not examined in earlier studies. Differences in the
experimental apparatus used for studying single- and
multi-joint movements introduce inconsistencies
between our work and other studies [15,22,27]. However,
the main features of our comparisons between paretic and
non-paretic arms are in agreement with earlier studies.
In addition to supporting other research findings that the
paretic arm moves more slowly and is profoundly weaker
than the non-paretic arm [15,28,29], we provided further
insight into the nature of impairments of voluntary move-
ment in stroke subjects by measuring the most important
kinematic and kinetic parameters. We also quantified the
movement smoothness of the arm trajectory using two
different computational measures. Our findings confirm
previous research [15,22,30] that the paretic arm acceler-
ates and decelerates multiple times during a single move-
ment, causing jerky movement in the paretic arm.
Mechanisms underlying impaired movement in stroke
Although the precise underlying mechanisms by which
disrupted descending cortical input affects voluntary func-
tion are uncertain, three major mechanisms have been
suggested as contributing factors to movement impair-
ment: abnormal muscle recruitment, weakness, and
altered spinal reflexes, specifically spasticity [1,2].
Abnormal muscle recruitment, in which a voluntary
movement is performed by synergistic patterns, can either
directly or indirectly lead to impairment by limiting inde-
pendent motion of different joints within the impaired
limb.
The immobility imposed by a weakness from a decrease in
neural drive command can reduce the voluntary force
shown in the MVC of the elbow extensors either directly
or indirectly. Such immobility may lead to disuse-related
muscular atrophy and/or contracture, which is secondary
to the loss of active range of motion. Animal studies have
shown that reduced neuronal drive leads to muscular
atrophy and subsequent physiological changes of the skel-
etal muscles [31]. The reciprocal inhibitory effects of spas-
tic elbow flexors on the voluntary activation of elbow
extensors may also be a cause of abnormal muscle recruit-
ment. This is supported by our findings that the MVC of
elbow extensors was significantly lower in spastic than
healthy arms (Figure 3B) and inversely correlated with
reflex stiffness gain of the elbow flexors [5].
Spasticity may also be affected by the mechanisms dis-
cussed earlier and may be linked to impaired function
through other mechanisms. Hypertonia causes hyperac-
tivity of spastic muscles that can lead to hypoactivity of
their antagonists through reciprocal inhibition [1,2].
These abnormalities may lead to shortening of the mus-
cles resulting in alteration of the muscle length-tension
relationship. These combined changes may ultimately
lead to impaired movement and function [28,32,33]. Our
findings support the relationship between spasticity and
impairments in voluntary movement by indicating that
the abnormal reduction in Vp and Ap of elbow voluntary
extension in the paretic group are strongly correlated with
the abnormal modulation of reflex stiffness gain [5]. Fur-
thermore, this relationship has been supported by find-
ings that reducing hypertonia by therapeutic
interventions, such as medication and functional electri-
cal stimulation, increases maximum voluntary force [3,7]
and improves function [4,7,6].
Movement smoothness
This study showed multiple phases of acceleration and
deceleration are involved in elbow extension of the
paretic arm in post-stroke subjects. Decreased smoothness
of the movement trajectory was noted in individuals with
stroke in the end-point trajectory during goal-directed
reaching [13,15,22]. Our findings provide further infor-
mation on the degraded movement smoothness in the
paretic arm by using two different computational meth-
ods to quantify smoothness.
NMU, and NJS have been used to quantify the movement
smoothness of reaching in individuals with stroke
[13,22,34], prenatal brain injury [23], and Parkinson's
disease [35]. However, it remains unclear which measure-
ment best detects changes in smoothness. Our results
demonstrate that both NMU and NJS were several times
greater for paretic than non-paretic arms and are therefore
sensitive enough to detect the decrease in smoothness of
a movement trajectory. One possible explanation is that
NMU and NJS are calculated from the angular velocity,
acceleration, and jerk, all of which are higher-order deriv-
atives of the angular position in which changes in posi-
tion are magnified by differentiation.
Mechanisms underlying the decreased smoothness in the stroke arm
Non-smooth movement in reaching may relate to deficits
in global movement trajectory planning and in the inabil-Journal of NeuroEngineering and Rehabilitation 2007, 4:45 http://www.jneuroengrehab.com/content/4/1/45
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ity to coordinate multiple joints [27]. Peripheral factors,
such as muscle strength, have not been directly related to
jerkiness of the end-point trajectory by other researchers
[22,34]. In our study, the movement involved a single
joint (elbow) with the upper arm fully stabilized so that
subjects did not have to overcome any interactions
between joints during movement. Subjects were
instructed to push out their forearm as fast as possible and
to stop when they reached the end of their range of move-
ment. They needed to plan the trajectory to the end point
with respect to the spatial location of the target (i.e. the
end of the range of motion) to achieve this task. Thus, the
non-smooth movement of the paretic arm may be a con-
sequence of impaired trajectory planning in stroke survi-
vors.
Decreased smoothness of elbow extension may be associ-
ated with spastic hypertonia of the elbow flexors. Fellows
et al.[11] found that in stroke subjects, the activation dura-
tion and the amplitude of biceps contractions were signif-
icantly increased with the peak velocity of elbow
extension, which was not present in normal control sub-
jects, suggesting abnormal co-activation pattern of elbow
flexors during rapid elbow extension may lead to a non-
smooth trajectory. In the current study, we found a corre-
lation between Vp and NMU (r = -0.65, using Spearman
correlation coefficients) indicating that the trajectory is
more segmented with the slower Vp of stroke survivors.
Others have also found Vp and Ap of elbow extension are
inversely correlated with the reflex gain of the elbow flex-
ors, indicating the impact of reflex hypertonia on the Vp
[5]. Given the correlation between Vp and movement
jerkiness reported in this study, the reflex hypertonia of
elbow flexors may also contribute to the lower smooth-
ness of the movement trajectory in elbow extension of
stroke subjects.
Can the non-paretic arm be used as control?
Several studies have shown that muscle strength and con-
trollability of the non-paretic arm is reduced in stroke sur-
vivors and it therefore, cannot serve as control for
evaluating the functional recovery of the paretic arm
[25,26]. However, the non-paretic arm offers advantages
over a healthy arm as a control primarily because within-
subject variability in biomechanical properties is small.
Our comparison of movement kinematics in non-paretic
and normal arms showed no significant differences
between non-paretic and normal arms. However, the sta-
tistical power for this comparison was smaller than 40%
for the measured parameters indicating a reduced chance
of detecting significant differences. Therefore, we can only
suggest that the non-paretic arm may be considered as
control for evaluating the performance of arm movements
as it eliminates inter-subject variability effects.
Movement impairments in different spastic populations
In all our SCI subjects, control of elbow muscles was com-
promised by an incomplete C4–C5 injury. Compared to
normal subjects, the spastic arm of SCI subjects moved
more slowly, had a smaller AROM, and a weaker MVC.
However, none of the smoothness measures was signifi-
cantly different from those of the normal arm. These find-
ings are consistent with previous findings that subjects
with C4–C6 incomplete SCI can generate smooth elbow
movement trajectories, although peak velocity is signifi-
cantly reduced [36].
The finding of relatively smooth movements in our SCI
subjects may relate to the integrity of the cortical motor
centers in this population which provide the needed capa-
bility in trajectory planning. In contrast to stroke, (where
lesions to the brain may reduce the control of movement
smoothness), in SCI subjects these parts of CNS are largely
intact, resulting in more smooth movement. In addition,
however, SCI subjects with C5–C6 injury usually generate
reaching movements by activating the agonist muscles
alone [37]. In many cervical SCI subjects, the anterior
horn cells at the lesion location are injured that may
dampen the normal spasticity at this level. Decreased
spasticity, and therefore reduced co-activation from the
antagonists during elbow extension, may also contribute
to a smooth trajectory in our SCI subjects. The contribu-
tion of either of these mechanisms for the preserved
smoothness trajectories in SCI is unclear.
Unlike the spastic SCI group, smoothness measures
(NMU and NJS) in the paretic group were significantly
greater in the paretic arm than the non-paretic arm. We
therefore expected smoothness measures of the spastic
arm in SCI to be significantly different from those of the
paretic arm in stroke. However, there was no significant
difference in smoothness measures between the two
patient groups. Further analysis of the data grouped by
level of performance (G, FP) reduced inter-subject varia-
bility and showed that in the FP group only, paretic arms
had smaller AROM_1MU and %AROM_1MU than spastic
SCI arms in subjects of the same performance level, indi-
cating a higher capability in SCI subjects to assemble and
scale muscle forces to generate a skillful movement. How-
ever, the reduced trajectory smoothness of the paretic
arms in the FP group, suggested by their smaller
AROM_1MU and %AROM_1MU, was not confirmed by
other smoothness measures (NMU and NJS). These
showed no significant differences between the paretic
arms and the spastic SCI arms in the FP group. When indi-
vidual data in the FP group were carefully examined, we
found two smoothness measures (NMU and NJS) for
spastic SCI arms had lower mean values and lower rank
scores than those in paretic arms. However, differences
were not statistically significant due to the small sampleJournal of NeuroEngineering and Rehabilitation 2007, 4:45 http://www.jneuroengrehab.com/content/4/1/45
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size in the subgroups. Future studies with larger samples
will be needed to further explore the differences in trajec-
tory planning and control between the stroke and SCI
subjects.
Correlations between kinematic and kinetic measures and 
ashworth score
The correlations between our objective measures of
impaired voluntary movements and Ashworth scores were
poor, although we did accept the global clinical assess-
ment that the subjects were spastic, since this was deter-
mined by independent clinical examination. These
findings indicate that MAS assessments are relatively unre-
liable as compared with more objective measures of spas-
ticity. There are at least three major reasons that may
explain why Ashworth scores were not well correlated to
our objective voluntary measures.
First, the Ashworth scale is a clinical measure designed to
assess muscle tone by manipulating the joint and measur-
ing its resistance to imposed movement. This movement
begins with the muscles in a quiescent state. It follows that
the Ashworth scale may not suitable for measuring active
movement; whereas we studied active arm movements.
Second, the Ashworth scale measures overall stiffness of
the joint, and this single number cannot provide informa-
tion regarding the characteristics of movement such as
range of motion, movement speed and acceleration, and
movement smoothness. It also cannot give us a measure
of muscle strength.
Finally, the Ashworth scale is neither objective nor quan-
titative. It is an ordinal number that represents the exist-
ence of tone or at the most the approximate severity of
tone, but it can neither characterize the contributions of
muscular and/or reflex components to tone nor their
modulation with position and velocity of the joint stretch.
This limitation is described in earlier publications in spas-
tic subjects with SCI [38] and stroke [39-44].
Conclusion
Our findings show significant differences in major kine-
matic, kinetic and movement smoothness parameters
between the paretic and non-paretic arm in individuals
with stroke. Surprisingly, although the cause and location
of injury are different in spastic stroke and SCI subjects,
there were no significant differences in the impairments
between the two groups, except for the movement
smoothness. This suggests that the nature of the impair-
ment in arm movement is similar in these two popula-
tions. Smoothness was significantly lower in the paretic
compared to the non-paretic arm in the stroke subjects,
whereas no significant changes in smoothness were evi-
dent in the SCI subjects. However, future studies with
larger sample sizes will be needed to further explore this
issue. Finally, there was no significant difference between
the non-paretic and normal arms suggesting that the non-
paretic arm may be used as a suitable control for stroke
subjects as it minimizes the adverse effects of inter-subject
variability.
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